Table of Contents Author Guidelines Submit a Manuscript
Journal of Chemistry
Volume 2017, Article ID 2380531, 11 pages
https://doi.org/10.1155/2017/2380531
Research Article

New Caffeic Acid Phenylethyl Ester Analogs Bearing Substituted Triazole: Synthesis and Structure-Activity Relationship Study towards 5-Lipoxygenase Inhibition

Department of Chemistry and Biochemistry, Université de Moncton, Moncton, NB, Canada E1A 3E9

Correspondence should be addressed to Mohamed Touaibia; ac.notcnomu@aibiauot.demahom

Received 27 February 2017; Accepted 9 April 2017; Published 4 May 2017

Academic Editor: Naoki Toyooka

Copyright © 2017 Pierre-Philipe Roy et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. W. R. Henderson Jr., “The role of leukotrienes in inflammation,” Annals of Internal Medicine, vol. 121, no. 9, pp. 684–697, 1994. View at Publisher · View at Google Scholar · View at Scopus
  2. C. Pergola and O. Werz, “5-Lipoxygenase inhibitors: a review of recent developments and patents,” Expert Opinion on Therapeutic Patents, vol. 20, no. 3, pp. 355–375, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. O. Kowal-Bielecka, K. Kowal, O. Distler, and S. Gay, “Mechanisms of disease: leukotrienes and lipoxins in scleroderma lung disease—insights and potential therapeutic implications,” Nature Clinical Practice Rheumatology, vol. 3, no. 1, pp. 43–51, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. J. N. Sharma and L. A. Mohammed, “The role of leukotrienes in the pathophysiology of inflammatory disorders: is there a case for revisiting leukotrienes as therapeutic targets?” Inflammopharmacology, vol. 14, no. 1-2, pp. 10–16, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. B. Samuelsson, S.-E. Dahlen, J. A. Lindgren, C. A. Rouzer, and C. N. Serhan, “Leukotrienes and lipoxins: structures, biosynthesis, and biological effects,” Science, vol. 237, no. 4819, pp. 1171–1176, 1987. View at Publisher · View at Google Scholar · View at Scopus
  6. E. Israel, J. Cohn, L. Dubé, and J. M. Drazen, “Effect of treatment with zileuton, a 5-lipoxygenase inhibitor, in patients with asthma: a randomized controlled trial,” Journal of the American Medical Association, vol. 275, no. 12, pp. 931–936, 1996. View at Google Scholar · View at Scopus
  7. O. Werz and D. Steinhilber, “Therapeutic options for 5-lipoxygenase inhibitors,” Pharmacology & Therapeutics, vol. 112, no. 3, pp. 701–718, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. A. S. Fischer, J. Metzner, S. D. Steinbrink et al., “5-Lipoxygenase inhibitors induce potent anti-proliferative and cytotoxic effects in human tumour cells independently of suppression of 5-lipoxygenase activity,” British Journal of Pharmacology, vol. 161, no. 4, pp. 936–949, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. J. Ghosh and C. E. Myers, “Inhibition of arachidonate 5-lipoxygenase triggers massive apoptosis in human prostate cancer cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 22, pp. 13182–13187, 1998. View at Publisher · View at Google Scholar · View at Scopus
  10. A.-P. Beauregard, J. Harquail, G. Lassalle-Claux et al., “CAPE analogs induce growth arrest and apoptosis in breast cancer cells,” Molecules, vol. 20, no. 7, pp. 12576–12589, 2015. View at Publisher · View at Google Scholar · View at Scopus
  11. Jérémie A. Doiron, Luc M. Leblanc, Martin J. G. Hébert et al., “Structure activity relationship of caffeic acid phenethyl ester analogs as new 5-lipoxygenase inhibitors,” Chemical Biology & Drug Design, vol. 89, no. 4, pp. 514–528, 2017. View at Google Scholar
  12. L. H. Boudreau, J. Maillet, L. M. LeBlanc et al., “Caffeic acid phenethyl ester and its amide analogue are potent inhibitors of leukotriene biosynthesis in human polymorphonuclear leukocytes,” PLoS ONE, vol. 7, no. 2, Article ID e31833, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. D. De Lucia, O. M. Lucio, B. Musio et al., “Design, synthesis and evaluation of semi-synthetic triazole-containing caffeic acid analogues as 5-lipoxygenase inhibitors,” European Journal of Medicinal Chemistry, vol. 101, pp. 573–583, 2015. View at Publisher · View at Google Scholar · View at Scopus
  14. E. M. Joshi, B. H. Heasley, M. D. Chordia, and T. L. Macdonald, “In vitro metabolism of 2-acetylbenzothiophene: relevance to zileuton hepatotoxicity,” Chemical Research in Toxicology, vol. 17, no. 2, pp. 137–143, 2004. View at Publisher · View at Google Scholar · View at Scopus
  15. L. H. Boudreau, N. Picot, J. Doiron et al., “Caffeoyl and cinnamoyl clusters with anti-inflammatory and anti-cancer effects. Synthesis and structure-activity relationship,” New Journal of Chemistry, vol. 33, no. 9, pp. 1932–1940, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. J. A. Doiron, B. Métayer, R. R. Richard et al., “Clicked cinnamic/caffeic esters and amides as radical scavengers and 5-lipoxygenase inhibitors,” International Journal of Medicinal Chemistry, vol. 2014, 12 pages, 2014. View at Publisher · View at Google Scholar
  17. C. E. Walsh, B. M. Waite, M. J. Thomas, and L. R. DeChatelet, “Release and metabolism of arachidonic acid in human neutrophils,” Journal of Biological Chemistry, vol. 256, no. 14, pp. 7228–7234, 1981. View at Google Scholar
  18. E. Shang et al., “Benzo[d]isothiazole 1, 1-dioxide derivatives as dual functional inhibitors of 5-lipoxygenase and microsomal prostaglandin E2 synthase-1,” Bioorganic & Medicinal Chemistry Letters, vol. 24, no. 12, pp. 2764–2767, 2014. View at Publisher · View at Google Scholar
  19. N. C. Gilbert, S. G. Bartlett, M. T. Waight et al., “The structure of human 5-lipoxygenase,” Science, vol. 331, no. 6014, pp. 217–219, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. J. Doiron, L. H. Boudreau, N. Picot, B. Villebonet, M. E. Surette, and M. Touaibia, “Synthesis and 5-lipoxygenase inhibitory activity of new cinnamoyl and caffeoylclusters,” Bioorganic and Medicinal Chemistry Letters, vol. 19, no. 4, pp. 1118–1121, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. Maestro, Schrödinger Release 2016-4, Maestro, Schrödinger, LLC, New York, NY, USA, 2016.